The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Drugs and Cosmetics from the Sea
Open accessAbstract
The marine environment is a rich source of both biological and chemical diversity. This diversity has been the source of unique chemical compounds with the potential for industrial development as pharmaceuticals, cosmetics, nutritional supplements, molecular probes, fine chemicals and agrochemicals. In recent years, a significant number of novel metabolites with potent pharmacological properties has been discovered from the marine organisms. Although there are only a few marine-derived products currently on the market, several robust new compounds derived from marine natural products are now in the clinical pipeline, with more clinical development. While the marine world offers an extremely rich resource for novel compounds, it also represents a great challenge that requires inputs from various scientific areas to bring the marine chemical diversity up to its therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peptide Neurotoxins from Fish-Hunting Cone Snails
Olivera, B. M., Gray, W. R., Zeikus, R., McIntosh, J. M., Varga, J., Rivier, J., de Santos, V., & Cruz, L. J. (1985) · Science · doi:10.1126/science.4071055 · Cited by 747
Gunasekera, S. P., Gunasekera, M., Longley, R. E., & Schulte, G. K. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00303a029 · Cited by 375
Biomedical Potential of Marine Natural Products
Ireland, C. M., Copp, B. R., Foster, M. P., McDonald, L. A., Radisky, D. C., & Swersey, J. C. (1993) · Pharmaceutical and Bioactive Natural Products · doi:10.1007/978-1-4899-2391-2_1 · Cited by 238
Biomedical potential of marine natural products
(1996) · BioScience · doi:10.2307/1312834 · Cited by 238
Hamann, M. T., & Scheuer, P. J. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00066a061 · Cited by 237
Ecteinascidin 743: A Minor Groove Alkylator That Bends DNA toward the Major Groove
Zewail-Foote, M., & Hurley, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990241l · Cited by 214
Phospholipase A2 Inhibitors from Marine Organisms
Potts, B. C. M., Faulkner, D. J., & Jacobs, R. S. (1992) · Journal of Natural Products · doi:10.1021/np50090a001 · Cited by 168
Didemnins and Tunichlorin: Novel Natural Products from the Marine Tunicate Trididemnum solidum
RINEHART, K. L. J., Kishore, V., Bible, K. C., Sakai, R., Sullins, D. W., & Li, K. (1988) · Journal of Natural Products · doi:10.1021/np50055a001 · Cited by 108
(2000) · KARGER eBooks · doi:10.1159/isbn.978-3-318-00599-8 · Cited by 98
Fishing for drugs from the sea: status and strategies
Vries, D. J. D., & Beart, P. M. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89045-8 · Cited by 82
SCIENCE/TECHNOLOGY: Supply Issues Complicate Trek Of Chemicals From Sea To Market
ROUHI, A. M. (1995) · Chemical & Engineering News · doi:10.1021/cen-v073n047.p042 · Cited by 49
Rinehart (2000) · doi:10.1002/(sici)1098-1128(200001)20:1<1::aid-med1>3.0.co;2-a
Cited by
Bhalerao, S., & Kadam, P. (2010) · International Journal of Ayurveda Research · doi:10.4103/0974-7788.59946 · Cited by 798
Martins, A., Vieira, H., Gaspar, H., & Santos, S. (2014) · Marine Drugs · doi:10.3390/md12021066 · Cited by 572
Marine actinomycetes: An ongoing source of novel bioactive metabolites
Subramani, R., & Aalbersberg, W. (2012) · Microbiological Research · doi:10.1016/j.micres.2012.06.005 · Cited by 453
Exploring the ocean for new drug developments: Marine pharmacology
Malve, H. (2016) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.171700 · Cited by 420
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2006) · Natural Product Reports · doi:10.1039/b502792f · Cited by 418
Metadata
- Authors
- Kijjoa, A., & Sawangwong, P.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2004-05-25
- Volume
- 2
- Issue
- 2
- Pages
- 73-82
- ISSN
- 1660-3397 (ISSN-L)
- OpenAlex
- W2105688727
- Cited by
- 267
- References
- 12
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.